Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India

Tropical Medicine and International Health

Volumn 13, Issue 7, 2008, Pages 934-942

  Mendelsohn, Andrea S ^a,b,c   Asirvatham, Jaya Ruth ^a   Mkaya Mwamburi, D ^b   Sowmynarayanan, T V ^a   Malik, Vandana ^a   Muliyil, Jayaprakash ^a   Kang, Gagandeep ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Lawrence Family Practice Residency   (United States)

Author keywords

Cost; Diarrhoea; Health economics; India; Paediatrics; Rotavirus; Vaccine

Indexed keywords

CHILD HEALTH; COST-BENEFIT ANALYSIS; DIARRHEAL DISEASE; FECES; GASTROENTERITIS; HEALTH EXPENDITURE; HEALTH SURVEY; HOSPITAL SECTOR; HOUSEHOLD EXPENDITURE; HOUSEHOLD INCOME; QUESTIONNAIRE SURVEY; SAVINGS; VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIARRHEA; ECONOMIC ASPECT; EMERGENCY WARD; FECES ANALYSIS; FEMALE; GASTROENTERITIS; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION COST; HOUSEHOLD; HUMAN; INCOME; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT; QUESTIONNAIRE; ROTAVIRUS; SCREENING;

CHILD, PRESCHOOL; COST OF ILLNESS; DIARRHEA; FEMALE; GASTROENTERITIS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INDIA; INFANT; MALE; QUESTIONNAIRES; ROTAVIRUS INFECTIONS;

ASIA; EURASIA; INDIA; SOUTH ASIA; TAMIL NADU; VELLORE;

ROTAVIRUS;

EID: 44949242446     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02094.x     Document Type: Article

References (17)

1. Banerjee I, Ramani S, Primrose B et al. (2006) Comparative study of the epidemiology of rotavirus in children from a community-based cohort and a hospital in South India. Journal of Clinical Microbiology 44, 2468 2474.
2. Banerjee I, Gladstone BP, LeFevre AM et al. (2007) Neonatal infection with G10P[11] rotavirus does not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. Journal of Infectious Diseases 195, 625 632.
3. Bresee JS, Glass RI, Ivanoff B Gentsch J (1999) Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing countries. Vaccine 17, 2207 2222.
4. Fischer TK, Anh DD, Antil L et al. (2005) Health care costs of diarrhoeal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. Journal of Infectious Diseases 192, 1720 1726.
5. Giaquinto C, Van Damme P, Huet F, Gothefors L Van der Wielen M (2007) Cost of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the reveal study. Journal of Infectious Diseases 195, S36 S44.
6. Isakbaeva ET, Musabaev E, Antil L et al. (2007) Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 25, 373 380.
7. Jain V, Parashar UD, Glass RI Bhan MK (2000) Epidemiology of rotavirus in India. Indian Journal of Pediatrics 68, 855 862.
8. Lu CY, Lauderdale TL, Fang YH et al. (2006) Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infectious Diseases 6, 176 184.
9. Nelson EA, Tam JS, Yu LM et al. (2005) Hospital-based study of the economic burden associated with rotavirus diarrhoea in Hong Kong. Journal of Infectious Diseases 192, S64 S70.
10. Parashar UD, Hummelman EJ, Bresee JS, Miller MA Glass RI (2003) The global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 9, 565 572.
11. Parashar UD, Gibson CJ, Bresee JS Glass RI (2006) Rotavirus and severe childhood diarrhea. Emerging Infectious Diseases 12, 304 306.
12. Podewils LJ, Antil L, Hummelman E et al. (2005) Projected cost-effectiveness of rotavirus vaccination for children in Asia. Journal of Infectious Diseases 192, S133 S145.
13. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al. (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 354, 11 22.
14. Vesikari T, Matson DO, Dennehy P et al. (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 354, 23 33.
15. WHO (2005) Guidelines for Estimating the Economic Burden of Diarrhoeal Disease with Focus on Assessing the Costs of Rotavirus Diarrhoea. (WHO/IVB/05.10) WHO, Geneva.
16. WHO (2007) World Health Statistics 2007. Health financing. http://www.who.int/whosis/database/core/core_select_process.cfm?countries= all&indicators=nha. Accessed: 25 June 2007.
17. Zimmerman CM, Bresee JS, Parashar UD, Riggs TL, Holman RC Glass RI (2001) Cost of diarrhoea-associated hospitalisations and outpatient visits in an insured population of young children in the United States. Pediatric Infectious Diseases Journal 20, 14 19.